Spontaneous mutants ofStaphylococcus aureus resistant to rifampin, rifamycin SV, streptovaricin, or streptolydigin were isolated and shown to be resistant due to chromosomal rather than plasmid mutations. Based on data concerning spontaneous mutation rates, genetic cotransduction rates, and in vitro sensitivity studies, four major antibiotic cross-resistance patterns were found. The genetic markers responsible for these cross-resistance patterns were shown to be separable by transduction. Nonpurified RNA polymerase activity in lysates of mutants showed the same sensitivity to these antibiotics as shown by the mutants on solid media. A model is proposed explaining possible structure-function relationships involved in the binding of these antibiotics to the RNA polymerase molecule and the mutations resulting in resistance to these antibiotics. This model includes generally overlapping but different-sized binding sites on the RNA polymerase protein coded for by similarly arranged mutable sites on the DNA.
Rifampin and the related antibiotics, rifamycin SV, streptovaricin, and streptolydigin, have proven to be useful in the study of procaryotic RNA polymerase. Studies in vitro have shown that these four antibiotics bind to RNA polymerase molecules and inhibit their activity.
In Escherichia coli, rifampin, rifamycin SV (26) , and streptovaricin (17) inhibit RNA polymerase from initiating transcription. Streptolydigin inhibits the elongation step of transcription in E. coli (5) and Bacillus megaterium (21) . In E. coli, the f8 subunit of the RNA polymerase is altered in mutants resistant to rifampin and streptolydigin (10, 21) and it is thought that streptovaricin also affects the ,B subunit (10) . In Staphylococcus aureus, it has also been shown that rifampin affects RNA polymerase activity (25) . Mutants resistant to some of these antibiotics have been isolated in E. coli (16, 27) , B. subtilis (8) , and Neisseria gonorrhoeae (20) . Mapping data from these mutants indicate linkage of the markers involved in resistance to the rifampin class of antibiotics. Resistances to rifampin and streptovaricin are generally more closely linked to each other than either marker is to streptolydigin resistance.
We have isolated chromosomal mutants of S. aureus which are resistant to rifampin, rifamycin SV, streptovaracin, and streptolydigin. Spontaneous mutation rates and cross-resistance pat-terns were determined for each mutant, and the mutants were mapped by transduction by using S. aureus bacteriophage 83. Four major antibiotic cross-resistance patterns were found, including a new combination in a mutant resistant to rifamycin SV and streptovaricin but sensitive to rifampin. The crude RNA polymerase activity in lysates of mutants showed the same sensitivity to these antibiotics as found for the mutant cells on solid media.
Recently, there has been an effort to standardize the many genotype symbols used for ,B subunit mutants (9) . Due to the many crossresistance patterns obtained in the study, the traditional rif (rifampin), rsv (rifamycin SV) stv (streptovaricin), and stl (streptolydigin) genotypes have been retained for clearer understanding when the genotypes of mutants are compared to phenotypes. In addition, however, rpoB (RNA polymerase ,B subunit) genotypes have been included in an effort to aid in standardization. R. S. Hayward has kindly assigned the first 100 rpoB genotypes in S. aureus to this laboratory.
MATERIALS AND METHODS
Bacterial strains and bacteriophage. Either S. aureus strain TM 655 or strain TM 656, a variant of TM 655 which lacks the plasmid for penicillinase production, was the parent of all the antibiotic-resistant strains used in this study. TM rpoBII rpoB20  rpoBIl rpoB21  rpoB22  rpoB22 rpoB23  rpoB22 rpoB24  rpoB22 rpoB25  rpoB26  rpoB26 rpoB27  rpoB26 rpoB28  rpoB22 rpoB24 rpoB29  rpoB22 rpoB24 rpoB29  rpoB30 S S S S Thislaboratory S S S S Thislaboratory R R R S TM655 R R R S TM655 R R R R TM655 R R R R TM97 R R R S TM655 S R R S TM655 S R R S TM655 S R R R TM128 R R R R TM136 S S R S TM655 S R R S TM150 R R R S TM153 R R R S TM153 R R R R TM 153 after two independent selection steps on rifampin and streptolydigin, respectively S R R S TM150 R R R R TM153 after three independent selection steps on rifamycin SV, rifampin, and streptolydigin, respectively R R R S TM150 R R R S TM150 S S R R TM150 S S S R TM655 S R R R TM192 R R R R TM192 R R R R TM192 S S S R TM655 S S R R TM215 R R R R TM215 S R R R TM219 R R R R TM242 'Based upon antibiotic used for isolation step. Some may be resistant to other antibiotics due to cross- DetermiLnation of mutation rates. Rates of mutation to resistance were determined for each of the four antibiotics. A total of 20 independent TSB cultures of strain TM 655 were used for each antibiotic. Each TSB tube was inoculated with approximately 102 cells and allowed to grow for 24 h at 350C. Each inoculum was derived from an independent colony. Each culture was.then plated in duplicate on BHIA plates which contained the appropriate antibiotic at the same concentration as described for mutant isolation. The plates were incubated for 24 h at 350C, and the number of mutants was counted. To determine how many cells were placed on each antibiotic-containing plate, cell counts were done on BHIA plates which contained no antibiotic. The mutation rate was calculated by the zero class calculation method of Luria and Delbruck (15) .
Crude RNA polymerase isolation and assay. In general, MICs for each antibiotic were lower in broth than on solid media. In both types of media, rifampin had the lowest MIC, followed by rifamycin SV, streptovaricin, and streptolydigin, respectively. Mutation rates. Table 3 presents the data on spontaneous mutation rates resulting in resistance to each of these antibiotics. Resistance to streptolydigin showed the highest mutation rate, followed by streptovaricin, rifamycin SV, and rifampin, respectively.
Isolation of mutants and analysis of cross-resistance patterns. A total of 191 independent mutants isolated on rifampin, 121 independent mutants isolated on rifamycin SV, 142 independent mutants isolated on streptovaricin, and 30 independent mutants isolated on streptolydigin were tested for cross-resistance to the three antibiotics which were not used for the initial selection. The cross-resistance patterns are shown in Table 4 . Generally, mutants isolated on rifampin were also resistant to rifamycin SV and streptovaricin. Generally, mutants isolated on rifamycin SV were either also resistant to rifampin and streptovaricin or also resistant to streptovaricin. Generally, mutants isolated on streptovaricin were also resistant to rifampin, rifamycin SV, or also resistant to rifamycin SV, or resistant only to streptovaricin. Generally, mutants isolated on streptolydigin were not resistant to any of the other three antibiotics. The same basic resistance patterns were obtained whether strain TM 655 or strain TM 656 was used to obtain mutants. Some of these mutants were used to produce the multiple-mutation step mutants. For example, strain TM 150, which was initially isolated for resistance to streptovaricin, was not resistant to any of the other three antibiotics after the first selection step. It was then used to select a mutant also resistant to rifamycin SV, but not to rifampin or streptolydigin. This two-mutation step, doubly resistant mutant was then plated on media containing rifampin to select for resistance to rifampin. Then, finally, this three-mutation step, triply resistant mutant was plated on media containing streptolydigin Chromosomal or plasmid location for markers responsible for resistance to rifampin. Figure 1 shows the effects of UV irradiation on donor phage used for transduction. With increasing time of irradiation the phage titer decreased and the transduction rate increased, indicating that the genetic markers for resistance to rifampin, and by association the rest of the markers in this study, are located on the chromosome rather than on a plasmid.
Transduction analysis of a number of single-step and multiple-step resistance mu (3, 4, 7, 22) . The MICs on solid media were higher than these in broth.
The various antibiotic concentrations in the media used to select mutants were considerably higher than the MICs for solid media. It was found that resistance to these antibiotics was an all-or-none phenomenon. For example, mutants resistant to 1 jig of rifampin per ml were also resistant to 100 ,tg/ml. This phenomenon was observed with all four antibiotics. Tsukamura observed similar results with Mycobacterium tuberculosis (24) .
All mutants isolated in this study were spontaneous mutants. The mutation rates were high enough that mutagens did not have to be used (Table 3) . Usually, plating 109 cells on an antibiotic-containing plate was sufficient to obtain 10 to 100 mutants.
The mutants selected for further study were assumed to be RNA polymerase mutants rather than permeability mutants, since the crude RNA polymerase activity of lysates made from mutants showed the same resistance patterns as the mutant cells did on solid media (Table 5) . It is not possible to say positively that the mutants not tested in this manner were also RNA polymerase mutants, but transduction data and general growth characteristics of the mutants strongly suggest that none of the mutants used in the study wer6 perneability mutants. Also, even though there is some reference in the literature to permeability mutants in B. subtilis (L. R. Brown and R. H. Doi, Bacteriol. Proc., p. 131, 1970) and M. tuberculosis (11) , practically all others mentioned are RNA polymerase mutants. Crude RNA polymerase activity in two of the mutants tested (TM 100 and TM 111) seemed to be enhanced by one or more of the antibiotics. It is unclear whether this was an actual stimulation or a result of the variability of assays resulting from the use of crude enzyme preparations. The primary purpose of this experiment was to verify that the mutants were RNA polymerase mutants rather than permeability mutants and these results verify that they were RNA polymerase mutants.
These mutations all appeared to have chromosomal rather than plasmid locations. Increased transduction rates after irradiation of the donor phage with UV light has been shown to indicate chromosomal rather than plasmid markers (1, 2, 19) . The plasmid of TM 655 carries a penicillinase marker which shows lower transduction rates when UV-irradiated phage are used. Figure 1 shows specific controlled data for one mutant, and UV irradiation routinely increased the rates of all transductions.
Some information concerning the nature of the genetic relationships between the mutations resulting in resistance to the four antibiotics was gained by analyzing the cross-resistance patterns of the mutants. Since these antibiotics are similar in their structure and mode of action, it is reasonable to believe there would be cross-resistance. Only certain specific cross-resistance patterns were observed for mutants isolated on each antibiotic (Table 4) .
The four major resistance patterns which emerged were resistance to the streptovaricin alone (hereafter called a type 3 mutation), resistance to streptovaricin and rifamycin SV together (hereafter called a type 2 mutation), resistance to streptovaricin, rifamycin SV, and rifampin together (hereafter called a type 1 mu-VOL. 137, 1979 on October 28, 2017 by guest http://jb.asm.org/ tation), and resistance to streptolydigin alone (hereafter called a type 4 mutation). Small numbers of mutants showing one of the first three patterns with the addition of streptolydigin resistance were also observed. Each of the four major patterns was theorized to represent a different alteration in the RNA polymerase molecule which affects the binding of these antibiotics to the enzyme. Others have reported information concerning cross-resistance between these antibiotics, generally in organisms other than S. aureus. In E. coli, mutants resistant to streptovaricin and rifampin as well as a small number of mutants resistant only to streptovaricin were detected (27) . In another study, a large number of B. subtilis rifampin mutants were all also resistant to streptovaricin, but not all mutants selected on streptovaricin were also resistant to rifampin (8) . Streptolydigin was also used in this study (8) , but no cross-resistance between streptolydigin and rifampin was detected. Another study (12) showed E. coli mutants selected on rifampin which were also resistant to streptolydigin. Mutants selected on streptovaricin became more, not less, sensitive to streptolydigin.
The cross-resistance patterns limited the steps which could be taken to create multiple-mutation step, multiply resistant mutants. For instance, all mutants selected on rifampin were type 1 mutants also resistant to rifamycin SV and streptovaricin. This meant it was impossible to use a rifampin-resistant mutant to select a streptovaricin-or rifamycin SV-resistant mutant. It was, however, possible to select mutants only resistant to streptovaricin (type 3 mutation) or streptolydigin (type 4 mutation), respectively. These patterns made it possible to produce four mutation step mutants resistant to all four antibiotics in two different sequences: (i) a type 3 mutation, followed by a type 2 mutation, followed by a type 1 mutation, followed by a type 4 mutation or (ii) a type 4 mutation, followed by a type 3 mutation, followed by a type 2 mutation, followed by a type 1 mutation. These sequences or parts of them were used to produce mutants to be used as donors in transductions, which could be used to see if these markers were separable by recombination.
A large number of transductions using various mutants as donors supported the theory that there are four genetically separable markers involved in this system. Results of some of these transductions are shown in Table 6 . binding sites or different-sized binding sites for each of these antibiotics and that some of the binding sites overlapped. Figure 2 is a schematic representation of this theory. The numbered areas represent mutational sites on the DNA as well as the corresponding antibiotic binding areas on the RNA polymerase f8 subunit. An alteration in area 1 would yield a type 1 mutant resistant to rifampin, rifamycin SV, and streptovaricin. An alteration in any part of area 2 would yield a type 2 mutant resistant to rifamycin SV and streptovaricin, but not rifampin. An alteration in any part of area 3 would yield a type 3 mutant resistant only to streptovaricin. An alteration in any part of area 4 would yield a type 4 mutant resistant to streptolydigin only. The mutation rate data (Table 3) supported Fig.  2 , in that the highest mutation rate occurred when streptovaricin was used for selection of mutants and the lower mutation rate occurred when rifampin was used for the selection of mutants. Although other factors, such as mutation "hot spots," could be involved, it is probable that a higher mutation rate indicates a larger section of DNA and, consequently, protein which can affect resistance (binding) to a particular antibiotic. Since resistance to streptolydigin generally did not occur in combination with resistance to the others, it is not possible to use mutation rates to assign a particular length to the streptolydigin-affected region. Also, this indicated that in S. aureus there is little or no overlap between the mutation/binding sites for streptolydigin and the other three antibiotics. This is in contrast to data reported for E. coli (12) which indicated that approximately 20% of mutants selected for resistance to rifampin were also resistant to streptolydigin.
The separation of the streptolydigin region from the other three is reasonable, since it has been shown to affect the elongation functions of the ft subunit rather than the initiation functions affected by the other three (10) . Whether the few mutants isolated which showed one of the first three major resistance pattems in combination with streptolydigin resistance are double mutants, large deletions, or actually represent overlap between mutable areas is unclear. It is doubtful that they are permeability mutants because one of the mutants of this type, TM 111, had an RNA polymerase which showed in vitro resistance to all four antibiotics.
Some recent work has been done with the RNA polymerase binding site for rifamycin in E. coli (23) , and the existence of two different binding sites for different rifamycin SV antibiotics on T-7 RNA polymerase has been postulated by Chamberlin and Ring (6), supplying supportive evidence for a multiple-binding-site model.
